Androgen deprivation therapy for prostate cancer: current status and future prospects

H Miyamoto, EM Messing, C Chang - The Prostate, 2004 - Wiley Online Library
… In order to prevent this phenomenon, administration of an antiandrogen or estrogen for a
week before and during the first few weeks of LH-RH agonist therapy is often employed [72]. …

Gender, racial and age differences in bladder cancer incidence and mortality

R Madeb, EM Messing - Urologic Oncology: Seminars and Original …, 2004 - Elsevier
Bladder cancer is the fourth most commonly diagnosed cancer in men and the eighth most
common in women in the United States. While clinicians who diagnose and treat the disease …

[HTML][HTML] Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

EM Messing, J Manola, M Sarosdy… - … England Journal of …, 1999 - Mass Medical Soc
Background Because the optimal timing of the institution of antiandrogen therapy for prostate
cancer is controversial, we compared immediate and delayed treatment in patients who …

Smoking and bladder cancer: a systematic review of risk and outcomes

…, JJ Crivelli, SF Shariat, FK Chun, EM Messing… - European urology …, 2015 - Elsevier
Context Cigarette smoking is an established risk factor for urothelial carcinoma. Objective To
elucidate the association between pretreatment smoking status, cumulative exposure, and …

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

EM Messing, J Manola, J Yao, M Kiernan… - The lancet …, 2006 - thelancet.com
Background Appropriate timing of androgen deprivation treatment (ADT) for prostate cancer
is controversial. Our aim was to determine whether immediate ADT extends survival in men …

Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904

E Scosyrev, EM Messing, R Sylvester, S Campbell… - European urology, 2014 - Elsevier
Messing had full access to all the data in the study and takes responsibility for the integrity
Messing certifies that all conflicts of interest, including specific financial interests and …

Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline

…, EK Lang, RJ Leveillee, EM Messing… - The Journal of …, 2012 - auajournals.org
Purpose : The purpose of this guideline is to provide a clinical framework for the diagnosis,
evaluation and follow-up of asymptomatic microhematuria. Materials and Methods : A …

Interstitial cystitis early diagnosis, pathology, and treatment

EM Messing, TA Stamey - Urology, 1978 - Elsevier
In a retrospective review, 52 Patients with interstitial cystitis have been studied. Patients with
Persistent lower tract irritative symptoms, repeatedly sterile urine, and negative urine …

Promotion of bladder cancer development and progression by androgen receptor signals

…, YC Hu, MY Tsai, S Yeh, EM Messing… - Journal of the …, 2007 - academic.oup.com
Background Males have a higher incidence of bladder cancer than females, but the reason
remains unknown. Unlike prostate cancer, human bladder cancer is not generally …

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial

EM Messing, J Manola, G Wilding, K Propert… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To evaluate the role of adjuvant interferon alfa after complete resection of locally
extensive renal cell carcinoma. Patients and Methods: A total of 283 eligible patients with pT3–…